Shvarts, G. Y. (2005). Pharmacoeconomic assessment of the effectiveness of glatiramer acetate (Copaxone®) in patients with multiple sclerosis. Ukrainian Neurosurgical Journal, (2), 85–91. https://doi.org/10.25305/unj.132316